EUVIMEDEUVIMED entdecken
Crossref

Treatment Adherence in Familial Mediterranean Fever Patients: Real-Life Data from Central Anatolia

Özlem Karakaş, Sualp Mete Sevil, Dudu Celik Tam

Türk Tıp Dergisi · 2025

DOI: 10.70852/tmj.1766066 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Türk Tıp Dergisi, 2025. Verfasst von Özlem Karakaş und 2 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Familial Mediterranean Fever (FMF) is a hereditary autoinflammatory disorder characterized by recurrent febrile episodes and serosal inflammation. Colchicine remains the cornerstone of FMF treatment, and adherence to therapy is critical to prevent disease flares and long-term complications such as amyloidosis. However, studies on treatment adherence in FMF are limited and report varying rates. This study aimed to evaluate treatment adherence in FMF patients and its association with clinical variables using real-life data from Central Anatolia.

Methods

This retrospective cross-sectional study included FMF patients aged 18 years and older who were followed at a tertiary rheumatology outpatient clinic and met the Tel-Hashomer diagnostic criteria. Demographic and clinical data were collected through structured interviews and medical record reviews. Treatment adherence was assessed via self-report. Associations between adherence and variables such as attack frequency, disease duration, drug adverse events, and follow-up visits were analyzed using Mann-Whitney U, Chi-square, and Spearman correlation tests as appropriate.

Results

70 patients (64.3% female, median age 33.5 years) were included. The majority (89.2%) reported regular adherence to treatment. Colchicine was the most commonly used drug, with a median dose of 1.5 mg/day. A weak, non-significant positive correlation was found between colchicine dose and the number of attacks in the last 6 months (ρ = 0.229, p = 0.071). There was no statistically significant association between treatment adherence and attack frequency (p = 0.622), disease duration (p = 0.134), follow-up frequency (p = 0.779), side effects (p = 0.582), proteinuria (p = 1.000), or marital status (p = 0.105).

Discussion

Despite high levels of reported adherence to colchicine among FMF patients, this did not consistently correlate with improved clinical outcomes. These findings highlight the complex nature of treatment adherence and underscore the need for individualized support strategies and objective adherence assessment tools in FMF management.

Zitieren

APA

Karakaş, Ö., Sevil, S. M., & Tam, D. C. (2025). Treatment Adherence in Familial Mediterranean Fever Patients: Real-Life Data from Central Anatolia. Türk Tıp Dergisi. https://doi.org/10.70852/tmj.1766066

Vancouver

Karakaş Ö, Sevil SM, Tam DC. Treatment Adherence in Familial Mediterranean Fever Patients: Real-Life Data from Central Anatolia. Türk Tıp Dergisi. 2025. doi:10.70852/tmj.1766066

BibTeX
@article{Karaka2025,
  author = {Karakaş, Özlem and Sevil, Sualp Mete and Tam, Dudu Celik},
  title = {Treatment Adherence in Familial Mediterranean Fever Patients: Real-Life Data from Central Anatolia},
  journal = {Türk Tıp Dergisi},
  year = {2025},
  doi = {10.70852/tmj.1766066}
}
Kostenlos starten →